MJardin Receives Health Canada Approval for Amendment of Ontario Facility

TORONTO and DENVER, Feb. 24, 2020 (GLOBE NEWSWIRE) -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that one of its indoor cannabis cultivation facilities “WILL”, located in Brampton, Ontario has received licensed approval from Health Canada to its amendment application to significantly increase its current operational space and production supply to full facility capacity.

The 32,800 square foot facility has received approval for eight additional grow areas and four additional operations areas which include grow, vegetative and mother rooms, as well as trim, dry, and packaging rooms. This amendment to its previous license for two rooms will allow WILL to produce its full capacity of 3,000 kg of dried flower and 900 kg of trim for a total of 3,900 kg. The Company is in the process of submitting the final amendment to bring the remaining 2 flower rooms onto the Health Canada license and expects this to be completed in the third quarter 2020.

“We are thrilled to have received this approval from Health Canada in a very timely manner,” said Pat Witcher, CEO of MJardin Group. “Our team has worked hard retrofitting the facility and getting eight of the ten additional rooms online. We look forward to completing the remaining two rooms but in the meantime will begin growing more of our premium high THC product and cultivating unique strains as part of our strategic partnership with Robes, Inc.”

MJardin previously announced that it has dedicated a portion of its canopy space to grow exclusive strains provided by its partner Robes Inc. including the esteemed BLLRDR strain.

About MJardin Group

MJardin Group’s mission is to set the standard for successful ownership and management of assets in the cannabis industry. Our Colorado founders spent a decade refining cultivation methodology, collecting and implementing data driven standards and designing state of the art facilities. Today, MJardin owns or manages multiple operations in two US states and three Canadian provinces, supplying the market with premium products. We are committed to our Canadian First Nation joint ventures and all our partnerships across the cannabis supply chain. MJardin is publicly listed on the CSE (MJAR) and the QXOTC (MJARF) with offices in Denver, Colorado and Toronto, Ontario. For more information, please visit www.mjardin.com